Moteur de recherche d’entreprises européennes
Financement de l’UE (3 929 699 €) : Innovation dans la modélisation du placenta pour la santé maternelle et fœtale Hor28/08/2017 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Innovation dans la modélisation du placenta pour la santé maternelle et fœtale
“The placenta is the least understood human organ but arguably one of the most important”-NIH Human Placenta Project . Innovation in Modelling Placenta for Maternal and Fetal Health (iPLACENTA) is a European Training Network (ETN), and will act as a springboard for promoting international, intersectoral and multi/inter-disciplinary training, career development and collaboration of fifteen early-stage researchers (ESRs) in Maternal and Fetal Health. iPLACENTA will improve our ability to study, model and visualise the placenta. iPLACENTA focuses on doctoral-level training and will be delivered by eleven participating universities located in ten different European countries. It coordinates research and training collaboration among world-leading academic institutions in Europe, providing a new combination of in-depth international expertise. iPLACENTA’s unique network aims are to improve our ability to study the placenta through in vitro and mathematical modelling (WP1&2). Whilst enhancing visualisation and assessment of the placenta in animal models and the clinic, thus enhancing investigation and prognosis of complicated pregnancies. To link the research to industrial exploitation, the network brings together three different businesses; Mimetas (MIM) (organ-on-a-chip developer) as a beneficiary, and Moor, a clinical-technology specialist, and industrial global brand FujifFilm VisualSonics (FUJ) as partners. Together they will work with academics and clinicians to develop new placenta-on-a-chip technology (WP1), in silico placenta modelling (WP2), new modalities of laser technology to visualise the placenta in vivo (WP3), improve maternal-cardiovascular assessment and validate novel ultrasound tools for diagnosis of complicated pregnancies (WP3). Cross-sectorial training delivered by Business and Law Schools, Industry, Clinical specialist and European leaders in OpenScience-OpenInnovation.
| Action on Pre-Eclampsia | ? |
| Aston University | 273 288 € |
| 247 873 € | |
| Institut National de la Sante et de la Recherche Medicale | 525 751 € |
| Katholieke Universiteit Leuven | 250 560 € |
| 510 749 € | |
| St George's Hospital Medical School | 546 576 € |
| UNIVERSITAET ROSTOCK | 249 216 € |
| UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK | 265 675 € |
| Universita Degli Studi DI Torino | 258 061 € |
| Universiteit Maastricht | 255 374 € |
| University of Dundee | 546 576 € |
https://cordis.europa.eu/project/id/765274
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Action on PRE-Eclampsia, Evesham, Royaume Uni.
Les visualisations de "Action on Pre-Eclampsia - Financement de l’UE (3 929 699 €) : Innovation dans la modélisation du placenta pour la santé maternelle et fœtale"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
